adenine has been researched along with Infant, Newborn, Diseases in 6 studies
Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Should treatment of chronic hepatitis B virus infection be necessary during pregnancy, tenofovir, listed by the FDA as pregnancy category B drug, is to be preferred." | 2.49 | [Interdisciplinary aspects of and new drugs for chronic hepatitis B]. ( Horváth, G, 2013) |
| " Secondary assessments included maternal HBV DNA reduction at delivery, and maternal or infant adverse events during follow up." | 1.56 | Efficacy and safety of tenofovir alafenamide fumarate for preventing mother-to-child transmission of hepatitis B virus: a national cohort study. ( Cao, L; Chen, B; Chen, R; Ding, Y; Fan, J; Gan, W; Huang, Y; Lin, C; Liu, Y; Pan, CQ; Sheng, Q; Wang, S; Wang, Y; Zhu, L, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, Y | 1 |
| Cao, L | 1 |
| Zhu, L | 1 |
| Huang, Y | 1 |
| Lin, C | 1 |
| Wang, Y | 1 |
| Liu, Y | 1 |
| Sheng, Q | 1 |
| Wang, S | 1 |
| Fan, J | 1 |
| Chen, R | 1 |
| Gan, W | 1 |
| Chen, B | 1 |
| Pan, CQ | 1 |
| Horváth, G | 1 |
| Brunell, P | 1 |
| Ch'ien, LT | 1 |
| Cannon, NJ | 1 |
| Charamella, LJ | 1 |
| Dismukes, WE | 1 |
| Whitley, RJ | 1 |
| Buchanan, RA | 1 |
| Alford, CA | 1 |
| Luby, JP | 1 |
| Johnson, MT | 1 |
| Jones, SR | 1 |
| Light, IJ | 1 |
| Linnemann, CC | 1 |
2 reviews available for adenine and Infant, Newborn, Diseases
| Article | Year |
|---|---|
[Interdisciplinary aspects of and new drugs for chronic hepatitis B].
Topics: Adenine; Antiviral Agents; Comorbidity; Drug Interactions; Drug Therapy, Combination; Female; Gastro | 2013 |
Antiviral chemotherapy.
Topics: Adenine; Amantadine; Antiviral Agents; Arabinose; Cytarabine; Cytomegalovirus Infections; Herpesviri | 1974 |
1 trial available for adenine and Infant, Newborn, Diseases
| Article | Year |
|---|---|
Antiviral drugs for the neonate--the risk-benefit ledger.
Topics: Adenine; Animals; Antiviral Agents; Arabinose; Brain; Brain Diseases; Clinical Trials as Topic; Cyta | 1975 |
3 other studies available for adenine and Infant, Newborn, Diseases
| Article | Year |
|---|---|
Efficacy and safety of tenofovir alafenamide fumarate for preventing mother-to-child transmission of hepatitis B virus: a national cohort study.
Topics: Abnormalities, Drug-Induced; Adenine; Adult; Alanine; Chemoprevention; China; Cohort Studies; DNA, V | 2020 |
Effect of adenine arabinoside on severe Herpesvirus hominis infections in man.
Topics: Adenine; Adenine Nucleotides; Arabinose; Female; Genital Diseases, Female; Herpesviridae Infections; | 1973 |
Neonatal herpes simplex infection following delivery by cesarean section.
Topics: Adenine; Anti-Infective Agents; Arabinose; Cesarean Section; Extraembryonic Membranes; Female; Herpe | 1974 |